Product Code: ETC5634674 | Publication Date: Nov 2023 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The cardiac marker testing market in Canada is essential for diagnosing and monitoring heart conditions. This market is driven by advancements in medical technology, increasing prevalence of cardiovascular diseases, and the demand for accurate and rapid diagnostic tests. Growth is supported by innovations in biomarker testing and increased awareness of heart health.
The cardiac marker testing market in Canada is expanding with the increasing prevalence of cardiovascular diseases and the demand for accurate diagnostic tools. Cardiac marker tests are used to detect biomarkers associated with heart conditions, providing valuable information for diagnosis and treatment. The market is driven by advancements in diagnostic technologies, the growing focus on early detection and personalized medicine, and the rise in healthcare spending. The emphasis on improving test accuracy and expanding testing options further contributes to market growth.
Challenges in the cardiac marker testing market in Canada include the need for advanced diagnostic technologies and the high cost of testing. The market is also affected by regulatory hurdles and competition from alternative diagnostic methods. Additionally, there is pressure to improve accuracy and reliability while managing costs.
Government policies in Canada prioritize healthcare innovation and support for diagnostic testing, including cardiac marker testing. Health Canada regulates the approval of testing devices and kits to ensure they meet safety and efficacy standards. Public health funding and insurance coverage through provincial healthcare systems also help expand access to advanced diagnostic tools, thus supporting the growth of the cardiac marker testing market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Cardiac Marker Testing Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Cardiac Marker Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Cardiac Marker Testing Market - Industry Life Cycle |
3.4 Canada Cardiac Marker Testing Market - Porter's Five Forces |
3.5 Canada Cardiac Marker Testing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Canada Cardiac Marker Testing Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.7 Canada Cardiac Marker Testing Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.8 Canada Cardiac Marker Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Canada Cardiac Marker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Canada Cardiac Marker Testing Market Trends |
6 Canada Cardiac Marker Testing Market Segmentations |
6.1 Canada Cardiac Marker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Canada Cardiac Marker Testing Market Revenues & Volume, By Reagents and Kits, 2021-2031F |
6.1.3 Canada Cardiac Marker Testing Market Revenues & Volume, By Instruments, 2021-2031F |
6.2 Canada Cardiac Marker Testing Market, By Biomarker Type |
6.2.1 Overview and Analysis |
6.2.2 Canada Cardiac Marker Testing Market Revenues & Volume, By Troponin I and T, 2021-2031F |
6.2.3 Canada Cardiac Marker Testing Market Revenues & Volume, By Creatine kinase-MB(CK-MB), 2021-2031F |
6.2.4 Canada Cardiac Marker Testing Market Revenues & Volume, By Natriuretic peptide (Bnp Or Nt-Probnp), 2021-2031F |
6.2.5 Canada Cardiac Marker Testing Market Revenues & Volume, By Myoglobin, 2021-2031F |
6.2.6 Canada Cardiac Marker Testing Market Revenues & Volume, By High-sensitivity C-reactive protein(hs-CRP), 2021-2031F |
6.2.7 Canada Cardiac Marker Testing Market Revenues & Volume, By Other Cardiac Biomarkers, 2021-2031F |
6.3 Canada Cardiac Marker Testing Market, By Disease |
6.3.1 Overview and Analysis |
6.3.2 Canada Cardiac Marker Testing Market Revenues & Volume, By Myocardial Infarction, 2021-2031F |
6.3.3 Canada Cardiac Marker Testing Market Revenues & Volume, By Congestive Heart Failure, 2021-2031F |
6.3.4 Canada Cardiac Marker Testing Market Revenues & Volume, By Acute Coronary Syndrome, 2021-2031F |
6.3.5 Canada Cardiac Marker Testing Market Revenues & Volume, By Atherosclerosis, 2021-2031F |
6.3.6 Canada Cardiac Marker Testing Market Revenues & Volume, By Ischemia, 2021-2031F |
6.4 Canada Cardiac Marker Testing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Canada Cardiac Marker Testing Market Revenues & Volume, By Laboratory Testing Facilities, 2021-2031F |
6.4.3 Canada Cardiac Marker Testing Market Revenues & Volume, By Point-Of-Care Testing Facilities, 2021-2031F |
6.4.4 Canada Cardiac Marker Testing Market Revenues & Volume, By Academic Institutions, 2021-2031F |
7 Canada Cardiac Marker Testing Market Import-Export Trade Statistics |
7.1 Canada Cardiac Marker Testing Market Export to Major Countries |
7.2 Canada Cardiac Marker Testing Market Imports from Major Countries |
8 Canada Cardiac Marker Testing Market Key Performance Indicators |
9 Canada Cardiac Marker Testing Market - Opportunity Assessment |
9.1 Canada Cardiac Marker Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Canada Cardiac Marker Testing Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.3 Canada Cardiac Marker Testing Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.4 Canada Cardiac Marker Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Canada Cardiac Marker Testing Market - Competitive Landscape |
10.1 Canada Cardiac Marker Testing Market Revenue Share, By Companies, 2024 |
10.2 Canada Cardiac Marker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |